Vonapanitase is a potentially transformative advance for patients. Learn more about our clinical programs.
Vascular access failures are common, serious and can have life-limiting consequences. Read about our focus on the difficult challenges facing hemodialysis patients.
Our dedication to improving patients’ lives is at the core of all we do. Hear directly from the people affected by kidney disease about the urgent need to develop new treatments to improve vascular access.